An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivors

Metformin and weight loss relationships with epigenetic age measures—biological aging biomarkers—remain understudied. We performed a post-hoc analysis of a randomized controlled trial among overweight/obese breast cancer survivors (N = 192) assigned to metformin, placebo, weight loss with metformin,...

Descripción completa

Detalles Bibliográficos
Autores principales: Nwanaji-Enwerem, Jamaji C., Chung, Felicia Fei-Lei, Van der Laan, Lars, Novoloaca, Alexei, Cuenin, Cyrille, Johansson, Harriet, Bonanni, Bernardo, Hubbard, Alan E., Smith, Martyn T., Hartman, Sheri J., Cardenas, Andres, Sears, Dorothy D., Herceg, Zdenko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684118/
https://www.ncbi.nlm.nih.gov/pubmed/34920739
http://dx.doi.org/10.1186/s13148-021-01218-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684118/
https://www.ncbi.nlm.nih.gov/pubmed/34920739
http://dx.doi.org/10.1186/s13148-021-01218-y

Ejemplares similares